View drug registration information details.


ItemsRegistration information
ID525
No525
Brand NameHERCEPTIN 150MG
IngredientsTRASTUZUMAB 150MG
Dosage FormPOWDER FOR SOLUTION FOR INFUSION
Primary PackagingVIAL
StorageSTORE AT 2 C-8 C
Shelf Life4 YEARS
Pack Size150 MG/VIAL/BOX
Dispensing CategoryPrescription only
ATC ClassificationXX
Pharmaceutical ClassANTINEOPLASTICS
IndicationsMETASTATIC BREAST CANCER AS MONOTHERAPY OR IN COMBINATION WITH PACLITAXEL OR DOCETAXEL OR AROMATASE INHIBITOR;- EARLY BREAST CANCER FOLLOWING SURGERY, CHEMOTHERAPY AND RADIOTHERAPY; ADVANCED GASTRIC CANCER IN COMBINATION WITH CAPECITABINE OR INTRAVENOUS 5 FLUOROURACIL AND PLATINUM AGENT.
ContraindicationsKNOWN HYPERSENSITIVITY TO TRASTUZUMAB OR TO ANY OTHER COMPONENT OF THE PRODUCT
Side EffectsFEVER AND CHILLS, ABDOMINAL PAIN, ASTHENIA, CHEST PAIN, HEADACHE, DIARRHEA, NAUSEA, VOMITING
Unit Price-
EDL No
DescriptionWHITE TO PALE YELLOW LYOPHILIZED CAKE GIVES CLEAR TO SLIGHTLY OPALESCENT LIQUID, COLORLESS AFTER RECONSTITUTION
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerROCHE DIAGNOSTICS GMBH
CountrySWITZERLAND
Import Registration No55'065 02
Import Registration Date2014-02-07
ActivityCERTIFICATE RELEASED
Applied Date2024-08-08
FDD Registration No07 I 2316/04
FDD Registration Date2024-09-25
Expiry Date2029-09-24

Back to drug list